Jianping Ye. Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetesJ. Acta Pharmaceutica Sinica B, 2023, 13(6): 2807-2808. DOI: 10.1016/j.apsb.2023.03.016
|
Citation:
|
Jianping Ye. Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetesJ. Acta Pharmaceutica Sinica B, 2023, 13(6): 2807-2808. DOI: 10.1016/j.apsb.2023.03.016
|
Jianping Ye. Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetesJ. Acta Pharmaceutica Sinica B, 2023, 13(6): 2807-2808. DOI: 10.1016/j.apsb.2023.03.016
|
Citation:
|
Jianping Ye. Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetesJ. Acta Pharmaceutica Sinica B, 2023, 13(6): 2807-2808. DOI: 10.1016/j.apsb.2023.03.016
|
DownLoad: